Oxford Biomedica plc (OTCMKTS:OXBDF) Sees Significant Increase in Short Interest

Oxford Biomedica plc (OTCMKTS:OXBDF) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 134,600 shares, an increase of 71.9% from the February 28th total of 78,300 shares. Based on an average daily volume of 2,000 shares, the days-to-cover ratio is currently 67.3 days. Currently, 0.1% of the company’s stock are sold short.

Oxford Biomedica Price Performance

Oxford Biomedica stock opened at $3.88 on Monday. Oxford Biomedica has a 52 week low of $2.44 and a 52 week high of $5.68. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48. The stock has a 50 day moving average of $4.49 and a 200-day moving average of $4.92.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.